Damoiseaux R A, van Balen F A, Hoes A W, de Melker R A
Department of General Practice, Utrecht University, The Netherlands.
Br J Gen Pract. 1998 Dec;48(437):1861-4.
Appropriate use of antibiotics is one of the major issues in medicine today. In most countries, acute otitis media in children is treated with antibiotics; however, the efficacy of antibiotic use in every acute otitis media is a controversial issue. It may be worthwhile looking for special risk groups that benefit more from antibiotic treatment for acute otitis media. Children under two years of age with acute otitis media are at risk of poor outcome.
To assess whether the current high prescription rates of antibiotics for acute otitis media in children under two years of age (being a risk group for poor outcome) are based on an established increased efficacy.
Systematic literature review and a quantitative analysis with an assessment of the methodological quality of published trials, comparing antibiotic treatment with non-antibiotic treatment in acute otitis media in children aged under two years.
Six trials were included. Trials from before 1981 had a poor methodological quality. Four were suitable for the quantitative analysis. Only two of them were truly placebo-controlled. Of these two, one included only recurrent acute otitis media and the other included only non-severe episodes. With these restricted data, no statistically significant difference was found between antibiotic-treated children and controls under two years of age with acute otitis media, judged on the basis of clinical improvement within seven days (common odds ratio = 1.31; 95% CI = 0.83-2.08).
The current high prescription rates of antibiotics among children under two years of age with acute otitis media are not sufficiently supported by evidence from published trials. New randomized placebo-controlled trials using reliable methodology are needed in this young age group.
合理使用抗生素是当今医学的主要问题之一。在大多数国家,儿童急性中耳炎采用抗生素治疗;然而,抗生素在所有急性中耳炎治疗中的疗效是一个有争议的问题。寻找从急性中耳炎抗生素治疗中获益更多的特殊风险群体可能是值得的。两岁以下患有急性中耳炎的儿童面临预后不良的风险。
评估目前两岁以下儿童(作为预后不良的风险群体)急性中耳炎抗生素高处方率是否基于已证实的疗效提高。
进行系统文献综述,并进行定量分析,评估已发表试验的方法学质量,比较两岁以下儿童急性中耳炎抗生素治疗与非抗生素治疗的效果。
纳入六项试验。1981年以前的试验方法学质量较差。四项适合进行定量分析。其中只有两项是真正的安慰剂对照试验。在这两项试验中,一项仅纳入复发性急性中耳炎,另一项仅纳入非重度发作。基于这些有限的数据,在以七天内的临床改善情况为判断依据时,两岁以下急性中耳炎儿童接受抗生素治疗组与对照组之间未发现统计学上的显著差异(共同比值比 = 1.31;95%置信区间 = 0.83 - 2.08)。
目前两岁以下急性中耳炎儿童抗生素的高处方率缺乏已发表试验证据的充分支持。需要在这个年轻年龄组开展采用可靠方法的新的随机安慰剂对照试验。